Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Nad Reduction (U.V.), Phosphohexose Isomerase

FDA product code KLJ · 1 cleared devices

Class 1 Clinical Chemistry
Regulation
21 CFR 862.1570
Review panel
CH
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1977-06-17 – 1977-06-17
↑